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Introduction
Epithelial to mesenchymal transition (EMT) represents a
phenotypic conversion by which epithelial cells lose their
polarity and cohesiveness and acquire migratory features
characteristic of fibroblasts. EMTs are required for
morphogenetic processes and tissue remodelling during
development, but are also involved in pathological situations
such as wound healing, inflammation and tumor invasion and
metastasis (Bissell and Radisky, 2001; Thiery, 2002). A wide
variety of biological agents from cytokines to transcription
factors has been found to promote either cell scattering or EMT
in cultured epithelial cells (Gotzmann et al., 2004). In a
previous work, we reported that podoplanin, a small mucin-
like transmembrane glycoprotein also known as PA2.26
antigen or T1 among other names, induced the conversion
from an epithelial to a fibroblast-like morphology when
ectopically expressed in keratinocytes (Scholl et al., 1999).
Podoplanin is expressed in a variety of normal cells and
tissues, including mesothelia, certain types of epithelia,
neuronal cells, osteocytes and endothelia of lymphatic
capillaries (Rishi et al., 1995; Wetterwald et al., 1996; Williams
et al., 1996; Scholl et al., 1999; Kotani et al., 2003; Schacht et
al., 2005; Breiteneder-Geleff et al., 1997; Breiteneder-Geleff et
al., 1999). Mice deficient for podoplanin die immediately after
birth owing to respiratory failure caused by malformation of
alveoli (Ramirez et al., 2003). The podoplanin null mice also
show defects in the lymphatic pattern formation associated
with congenital lymphedema, dilation of vessels and
diminished lymphatic transport (Schacht et al., 2003). These
data point to an important role for podoplanin in the
development of the lung and lymphatic vascular system, but its
precise biological function remains poorly understood.
Podoplanin expression is upregulated in different types of
experimental and human tumors, including squamous cell
carcinomas of the skin, lung, esophagus, cervix, larynx and
oral cavity (Gandarillas et al., 1997; Martín-Villar et al., 2005;
Schacht et al., 2005; Kato et al., 2005; Wicki et al., 2006),
colorectal adenocarcinomas (Kato et al., 2003), testicular germ
cell tumors (Kato et al., 2004; Schacht et al., 2005) and
mesotheliomas (Chu et al., 2005). In squamous cell
carcinomas, podoplanin expression is frequently restricted to
the invasive front (Martín-Villar et al., 2005; Wicki et al.,
2006), and in some tumors correlates with downregulation of
the cell-cell adhesion protein E-cadherin (Martín-Villar et al.,
2005). Confocal and immunoelectron microscopy studies
aimed at studying its subcellular localization revealed that
podoplanin is concentrated at actin-rich microvilli and plasma
membrane projections, where it colocalizes with members of
the ERM (ezrin, radixin, moesin) protein family (Scholl et al.,
1999; Martín-Villar et al., 2005). ERM proteins link integral
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membrane proteins to the cortical actin cytoskeleton and
participate in signal transduction pathways that regulate cell
motility and adhesion (Bretscher et al., 2002). The presence of
podoplanin at cell-surface projections and the finding that ezrin
and moesin, but not radixin, can be coimmunoprecipitated with
podoplanin from cell lysates suggested that this glycoprotein
is involved in motility processes (Scholl et al., 1999). Further
studies showed a pro-migratory function for podoplanin,
because its expression in immortalized or premalignant
keratinocytes either stimulated cell scattering (Martín-Villar et
al., 2005) or promoted an EMT associated with increased
invasive and metastatic features (Scholl et al., 1999; Scholl et
al., 2000). In both cases, podoplanin stimulated the formation
of plasma membrane extensions concomitantly with a major
reorganization of the actin cytoskeleton and redistribution of
ezrin to cell-surface protrusions (Scholl et al., 1999; Martín-
Villar et al., 2005). Taken together, these data suggested an
involvement of podoplanin in cell migration and invasiveness
during tumor progression. We reasoned that an important cue
for this function should be its ability to reorganize the actin
cytoskeleton through recruitment of ERM proteins.
In this article, we show that wild-type human podoplanin
promotes a complete EMT in Madin-Darby canine kidney
(MDCK) type-II epithelial cells, a well-characterized cellular
model to analyze the molecular mechanisms of epithelial cell
plasticity (Gotzmann et al., 2004). The key elements for
podoplanin to promote this phenotypic conversion are its
ability to interact with ERM proteins through a cluster of basic
amino acids within its cytoplasmic tail and the regulation of
RhoA GTPase activity.
Results
The binding of podoplanin to ERM proteins requires a
juxtamembrane cluster of basic amino acids.
The 162 amino acid human podoplanin molecule contains an
ectodomain (EC) with a high proportion of O-glycosylated S
and T residues, a membrane-spanning domain (TM) and a
short cytoplasmic tail (CT) of only nine amino acids (Fig. 1).
The TM and CT domains are highly conserved across species
(Zimmer et al., 1999; Martín-Villar et al., 2005; Kaneko et al.,
2006). Within the CT domain the only obvious functional motif
is a cluster of basic amino acids (Fig. 1, bold) shared by
transmembrane proteins of the microvillus that has been shown
to be involved in direct binding to ERM proteins (Yonemura
et al., 1998). However, although coimmunoprecipitation
experiments suggested an association of podoplanin with ezrin
and moesin (Scholl et al., 1999), no proof for a direct
interaction of the podoplanin endodomain with these
cytoskeletal linkers exists. To analyze whether podoplanin
binds ERM proteins directly through this cluster of basic
residues, we expressed the wild-type cytoplasmic tail of human
podoplanin (PCT) as a fusion protein with glutathione-S-
transferase (GST), and tested whether the substitution of
positively charged residues (RK…R) by uncharged polar
amino acids (see Fig. 1) affected the interaction of PCT with
purified recombinant full-length ezrin and moesin or their N-
terminal sequences (N-ERMAD domains). Although both
controls (GST-Sepharose and uncoupled Sepharose) bound
some ezrin and moesin, the interaction of these proteins with
GST-PCT was clearly increased over the non-specific
background (Fig. 2A). The same occurred with the CT of the
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cell-surface receptor CD44, used in this experiment as a
positive control (Hirao et al., 1996; Legg and Isacke, 1998;
Yonemura et al., 1998). Phosphatidylinositol 4,5-bisphosphate
(PIP2), a positive regulator of ERM binding to membrane
proteins (Bretscher et al., 2002), enhanced the interaction of
ezrin and moesin with the CTs of both podoplanin and CD44
(data not shown), as demonstrated previously for CD44 (Hirao
et al., 1996). Mutation of one (PCT.N), two (PCTQN) or all
three (PCTQN.N) basic amino acids highly decreased the
binding of PCT to ezrin and moesin, although PCT.N (in which
only the most C-terminal R159 was mutated) appeared to
conserve some specific binding activity, particularly to moesin.
These data indicate that the motif RK…R within the
podoplanin endodomain is able to interact directly with ERM
proteins in vitro.
To ascertain whether this cluster of basic residues mediates
the binding of podoplanin to ERM proteins in vivo, we
engineered several constructs encoding wild-type or mutant
podoplanin proteins fused to enhanced yellow fluorescent
protein (EYFP). Mutant proteins were obtained that lacked the
cytoplasmic tail (PCT) or in which the juxtamembrane cluster
of basic amino acids was substituted by uncharged polar
residues, as above (see Fig. 1). Wild-type podoplanin (PWT)
and the mutant constructs fused to EYFP were cotransfected
with enhanced cyan fluorescent protein (ECFP)-tagged ezrin in
MDCK type-II cells and the interaction between ezrin and
podoplanin proteins determined by fluorescence resonance
energy transfer (FRET). In contrast to MDCK type-I cells,
MDCK type-II cells do not express endogenous podoplanin
(Zimmer et al., 1999) (our own results). FRET efficiency
(FRETeff) between EYFP-tagged podoplanin constructs and
ECFP-tagged ezrin was monitored by acceptor photobleaching
in different cells and cell regions (Fig. 2C-E). The mean
FRETeff value for wild-type podoplanin was 27.1%, indicating
that a substantial proportion of PWT is complexed with ezrin
in vivo. FRETeff decreased to about 5.9% in cells expressing
PCT.N, whereas FRETeff values fall to zero in cells expressing
mutant PCT, PCTQN.N and PCTQN (Fig. 2B). These results
Fig. 1. Schematic representation of podoplanin fusion constructs
used for transfection. Numbers indicate podoplanin amino acid
sequences (Martín-Villar et al., 2005) conserved in the construct. CT,
cytoplasmic domain; EC, ectodomain; FP, fluorescent protein (EYFP
or EGFP) used for the experiments specified in the text; SP, signal
peptide; TM, transmembrane domain. Basic amino acids (bold)
within the CT domain were substituted by uncharged polar residues
(bold and underlined).
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4543Podoplanin and epithelial-mesenchymal transition
demonstrate that in vivo association of podoplanin with ezrin
is mainly mediated by the juxtamembrane dipeptide RK.
Mutation of the most C-terminal residue R159 significantly
impaired but did not prevent this association.
Podoplanin induces an EMT in MDCK cells through the
cytoplasmic domain
In a preliminary test in which the wild-type human podoplanin
cDNA cloned into the pcDNA3 expression vector (Martín-
Villar et al., 2005) was stably expressed in MDCK type-II cells,
we found a dramatic change from an epithelial to a fibroblast-
like morphology (data not shown). Therefore, to investigate
which region of the molecule is required to promote this
morphological change, PWT and the mutant constructs fused
to enhanced green fluorescent protein (EGFP), including one
that lacked the ectodomain (PEC, see Fig. 1), were stably
expressed in MDCK cells. All selected clones expressing PWT,
PEC or PCT.N exhibited a clear fibroblastic morphological
appearance. By contrast, cells expressing PCT, PCTQN.N
and PCTQN maintained the epithelial morphology, as did
control clones expressing EGFP alone (EGFP). Two clones of
each construct were then selected for further studies. The total
level of podoplanin expression and the size of the exogenous
proteins were analyzed by western blotting (Fig. 3A). We also
monitored the expression of differentiation protein markers.
Fibroblastic clones induced by PWT and PEC had lost the
expression of epithelial markers, such as E-cadherin. They also
synthesized reduced levels of cytokeratin 8, -catenin and
Fig. 2. Podoplanin binds to ERM proteins through a cluster of basic amino acids within its cytoplasmic tail. (A) Association of ezrin and
moesin with podoplanin CT. GST and GST fusion proteins bound to Sepharose beads were incubated with purified recombinant full-length
ezrin or moesin or their N-ERMADs. Proteins bound to the beads were fractionated by SDS-PAGE followed by western blotting using anti-
ezrin or anti-moesin antibodies. CD44-CT was used as a positive control. (B) FRETeff values for cells coexpressing EYFP/Ezrin-ECFP (n=5),
PWT-EYFP/Ezrin-ECFP (n=14), PCT-EYFP/Ezrin-ECFP (n=7), PCTQN.N-EYFP/Ezrin-ECFP (n=7), PCTQN-EYFP/Ezrin-ECFP (n=6) and
PCT.N-EYFP/Ezrin-ECFP (n=10). Note the significant reduction (**P<0.01) of FRETeff in PCT.N with respect to PWT and the absence of
FRET in PCTQN.N, PCTQN and PCT cell transfectants. (C-E) Confocal fluorescence images showing acceptor photobleaching FRET
analysis in MDCK cell transfectants. Images of representative cells coexpressing Ezrin-ECFP with PWT-EYFP (C), PCT-EYFP (D) or
PCT.N-EYFP (E) are shown. ECFP and EYFP emission signals were collected before (left panels) and after (right panels) EYFP
photobleaching in the boxed regions. An increased ECFP fluorescence signal after photobleaching indicates FRET. The FRETeff is represented
in the bottom panel on a pseudocolor cell map with scale shown on the right.
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p120 catenin (ctn) isoform 3 (the main p120 ctn form expressed
in epithelial MDCK cells) (Sarrio et al., 2004). Conversely,
these cells had increased expression of N-cadherin, p120 ctn
isoform 1 and fibronectin (Fig. 3A): all mesenchymal markers
upregulated during EMT (Cavallaro and Christofori, 2004;
Sarrio et al., 2004). Epithelial MDCK cells expressing
PCTQN.N and PCTQN retained E-cadherin and cytokeratin
levels and did not switch to expression of N-cadherin.
Interestingly, clones expressing PCT.N, despite their
fibroblastic morphology, retained expression of E-cadherin
(although at a reduced level in clone 1), p120 ctn isoform 3
and cytokeratin 8, whereas expression of N-cadherin and p120
ctn isoform 1 was upregulated (Fig. 3A). These data indicated
that MDCK cells expressing PCT.N have an intermediate
phenotype between epithelial and mesenchymal (which we
have termed fibroblastoid). No substantial change in the
expression levels of mesenchymal vimentin was observed in
the different clones regardless of their epithelial or fibroblastic
morphology. Nevertheless, vimentin, which is already
significantly expressed in MDCK cells (Peinado et al., 2003)
(see also Fig. 3A), was better organized in a clear filament
network in fibroblast-like cells induced by PWT and PEC in
comparison to epithelial cell clones (Fig. S1 in supplementary
material). As expected, PCT.N-MDCK cells were positively
stained for E-cadherin, but the protein was relocated from cell-
cell contacts to the cytoplasm, indicating a loss of E-cadherin
function at cell-cell junctions (Fig. S1 in supplementary
material). A summary of the phenotypic changes produced in
MDCK cells by wild-type and mutant podoplanin proteins is
presented in Table 1.
RT-PCR analysis showed that loss of E-cadherin expression
in PWT and PEC cell transfectants occurred at the
transcriptional level (Fig. 3B). Since several transcription
repressors of E-cadherin, such as the zinc finger factors Snail
and Slug, have been found to promote EMT (Cano et al., 2000;
Batlle et al., 2000; Bolós et al., 2003), and Snail appears to be
involved in the EMT induced by TGF-1 in
MDCK cells (Peinado et al., 2003), we analyzed
the mRNA levels of these transcription factors in
the transfectants. No clear correlation could be
established between the mRNA transcript levels
and the level of E-cadherin expression or the
phenotype of the different cell clones, suggesting
that podoplanin-induced EMT did not involve
upregulation of Snail or Slug transcription factors.
In summary, these results indicate that
expression of wild-type podoplanin in MDCK
cells induces a complete EMT associated with
reprogramming of differentiation-related gene
expression. The crucial region of the molecule
involved in this transition appears to be the cluster
of basic residues within the cytoplasmic tail
responsible for binding to ERM proteins,
particularly the juxtamembrane dipeptide RK.
Localization of podoplanin at cell-surface
protrusions does not require the cytoplasmic
tail or the ectodomain
The subcellular localization of wild-type and
mutant podoplanin proteins was analyzed by
confocal microscopy. To determine the fraction of
the exogenous protein that was specifically
directed to the cell surface, we performed a
comparison between the fluorescence signal due to
EGFP and the signal obtained after in vivo pre-
embedding staining (at 4°C) using either a specific
antibody recognizing the podoplanin ectodomain
(Martín-Villar et al., 2005) or an anti-EGFP
antibody (for detection of PEC). As shown in
Fig. 4, PWT was distributed all along the plasma
membrane concentrated at cell-surface protrusions
(microvilli, filopodia and ruffles), as previously
reported (Scholl et al., 1999; Martín-Villar et al.,
2005). Patchy staining was also seen in the
cytoplasm, indicating the presence of podoplanin
at internal membrane structures (see below).
Deletion of the ectodomain did not alter this
pattern of expression, although the amount of
PEC directed to the cell surface was substantially
Journal of Cell Science 119 (21)
Fig. 3. MDCK cells expressing podoplanin undergo an EMT that depends on the
cytoplasmic domain. (A) Western blot analysis of podoplanin proteins and of
differentiation-related markers in MDCK-derived cell clones expressing EGFP
(control) and PWT, PCT, PEC, PCTQN.N, PCTQN or PCT.N fusion proteins.
(B) Expression of E-cadherin, Snail and Slug mRNA transcripts by RT-PCR.
GAPDH was amplified as a control for the amount of cDNA present in each
sample. The RT- lane shows the results of amplification in the absence of cDNA.
The morphology of the cell transfectants is indicated below (E, epithelial; F,
fibroblastic).
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4545Podoplanin and epithelial-mesenchymal transition
reduced with respect to PWT, because a
significant fraction of the truncated
molecule had a perinuclear location,
probably concentrated at the Golgi
apparatus. Interestingly, neither deletion of
the cytoplasmic tail nor mutation of the
ERM-binding sites prevented localization of
the mutant proteins at cell-surface
protrusions: PCT, PCTQN.N and PCTQN
proteins localized on the apical and lateral
surfaces of polarized epithelial MDCK cells,
concentrated at microvilli and cell-cell
junctions (Fig. 4). On the other hand, the
subcellular distribution of mutant PCT.N did
not differ significantly from that of PWT.
These results suggest that neither the
ectodomain nor the association of
podoplanin with the cytoskeleton through
the cytoplasmic tail is required for
localization of podoplanin at cell-surface
protrusions.
We also studied the organization of the
actin cytoskeleton in the cell transfectants
(Fig. S2 in supplementary material).
Epithelial MDCK cells transfected with
mutant PCT, PCTQN.N and PCTQN
showed strong cortical actin bundles and
short thin stress fibers: the same pattern
exhibited by the parental cell line and
control clones. These cells also showed
small vinculin-containing focal contacts. In
cells expressing PWT, PEC or PCT.N,
however, a reorganization of the actin
cytoskeleton concomitantly with the
induced morphological changes was
observed. Thus, cortical actin bundles
disappeared in these fibroblast-like cells,
Table 1. Summary of the phenotypic changes induced by podoplanin constructs in MDCK cells
p120 p120 Cell migration Invasiveness RhoA activity 
Construct Morphology E-CD N-CD ctn i.3 ctn i.1 K8 Fn (wound healing) (Matrigel) (cell lysates)
Control (EGFP) Epithelial + +/– ++ – + + Collective/Slow – –
PWT Fibroblastic (well spread) – ++ +/– + – ++ Individual/Fast ++ +
PEC Fibroblastic (elongated) – ++ +/– + – ++ Individual/Fast ++ +
PCT Epithelial + +/– ++ – + + Mixed/Intermediate + – 
PCTQN.N Epithelial + +/– ++ – + + Collective/Slow – –
PCTQN Epithelial + – ++ – + + Collective/Slow – –
PCT.N clone 1 Fibroblastic (elongated) +/– ++ + + + + Individual/Fast ++ +
PCT.N clone 2 Fibroblastic (elongated) + + + + + + Individual/Fast ++ +/–
CD, cadherin; ctn, catenin; Fn, fibronectin; K, cytokeratin.
Fig. 4. Subcellular localization of wild-type and
mutant podoplanin proteins. Confocal images of
horizontal (x-y) and vertical (x-z) sections of
MDCK cells expressing the indicated
podoplanin proteins fused to EGFP are shown.
The exogenous proteins specifically expressed at
the cell surface were detected by in vivo pre-
embedding staining using antibodies either
recognizing the podoplanin EC domain or EGFP
(for detection of PEC).
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Fig. 5. Podoplanin-induced EMT is associated with increased migratory and
invasive abilities. (A) In vitro wound-healing assay. Confluent cell cultures were
scratched with a pipette tip to produce a wound and analyzed by time-lapse video
microscopy. Images of the wounded area immediately (0 hours) and 12 hours
after the incision was made are shown. Arrows in PCT indicate individual cells
moving into the wound as fibroblasts. An animated sequence of these data is
shown in supplementary material Movie 1. In the bottom panel a graph shows
quantification of cell migration from three independent experiments. **P<0.01;
***P<0.001 vs control (EGFP) cells. (B) Matrigel invasion assay. Cell
transfectants expressing EGFP-tagged wild-type and mutant podoplanin proteins
were seeded on a 24-well Matrigel invasion chamber. FBS (5%) was used as a
chemoattractant. Fluorescent cells that invaded the Matrigel-coated filter after 24
hours were detected by confocal microscopy. Images were acquired each 2 m
along the z-axis and quantified by fluorescence intensity profiles. Vertical (x-z)
sections of the filter are shown below. Results are representative of two
experiments.
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4547Podoplanin and epithelial-mesenchymal transition
whereas F-actin accumulated at lamellipodia and ruffles.
Nevertheless, well-spread PWT-MDCK fibroblasts showed
more-pronounced focal contacts and longer and thicker stress
fibers than elongated MDCK cells expressing PEC or PCT.N
(Fig. S2 in supplementary material).
Dynamics of migration in MDCK cells expressing wild-
type and mutant podoplanin proteins 
To examine whether the observed phenotypic changes in
MDCK cell transfectants were associated with increased
motility, we performed an in vitro wound-healing assay. PWT-
and PEC-MDCK cells were able to repopulate a wound made
12 hours earlier in a confluent culture, whereas closure of the
wounds made in MDCK or control cell cultures was less than
50% (Fig. 5A). PCT.N-MDCK cells also had high migratory
abilities, comparable with those of cells expressing PWT and
PEC. Time-lapse video observations showed that fibroblast-
like PWT-, PEC- and PCT.N-MDCK cells migrated
individually, extending and retracting protrusions and
continually changing their orientations and shapes (Fig. 5A and
Movie 1 in supplementary material). By contrast, epithelial
cells expressing PCTQN.N and PCTQN migrated collectively,
maintaining cell-cell contacts (Fig. 5A and Movie 1 in
supplementary material) following the principles reported for
migration of parental MDCK cells (Matsubayashi et al., 2004;
Faroqui and Fenteany, 2005). Surprisingly, epithelial PCT-
MDCK cells exhibited an intermediate behavior, in which
migration was significantly reduced when compared with
fibroblast-like cell lines, but those cells migrated faster than the
other epithelial cell transfectants. The dynamics of cell
migration in PCT-MDCK wounds were similar to those
described for control cells, although in this case the speed of
movement was higher and contacts between marginal cells and
their following neighbours became weaker, resulting in
numerous individual cells moving as fibroblasts into the wound
(arrows in Fig. 5A and Movie 1 in supplementary material).
We also studied the ability of the cell transfectants to invade
into a reconstituted basement membrane (Matrigel).
Invasiveness was highly enhanced in fibroblast-like PWT-,
PEC- and PCT.N-MDCK cells with respect to epithelial cells
expressing PCTQN.N, PCTQN and control clones (Fig. 5B).
As in the in vitro wound-healing assay, PCT-MDCK cells
showed an intermediate behavior between those two groups of
transfectants.
Fluorescence time-lapse confocal microscopy on isolated
MDCK cells expressing wild-type or mutant podoplanin
proteins fused to EGFP allowed us to visualize the dynamics of
the subcellular distribution of podoplanin during cell
locomotion (Fig. 6 and Movies 3-5 in supplementary material).
PWT was present at the edge of lamellipodial extensions, but it
disappeared from attached lamellipodia (asterisk) whereas it
remained on the top of ruffles moving centripetally across the
cell surface. In addition, podoplanin clustered at the cell tail
(arrowhead) before the rearmost adhesions to the substratum
Fig. 6. Dynamics of podoplanin subcellular localization during cell locomotion. Isolated MDCK cells expressing EGFP-tagged PWT, PEC
and PCT proteins were imaged by capturing sections of 0.5 m every 10 minutes for 4 hours. Images in all panels correspond to 3D
reconstructions. Arrowheads indicate podoplanin fluorescence signal concentrated at the leading edge of lamellipodial extensions and on the
retracting tail, whereas asterisks indicate loss of fluorescence signal on lamellipodial extensions attached to the substratum. The direction of cell
migration is indicated by arrows. Animated sequences of these data are shown in supplementary material Movies 3-5.
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disassembled and the tail retracted. These observations suggest
that podoplanin might be involved in ruffling activity as well as
in retractive processes. A substantial amount of podoplanin was
also seen associated with internal membranous structures
(probably the Golgi system) and on the surface of vesicles
located close to the plasma membrane or surrounding the Golgi
apparatus (see Movie 2 in supplementary material). The
importance of this latter observation remains to be investigated.
No significant change was observed in the distribution of
mutant PEC (or PCT.N) with respect to PWT during cell
locomotion, although migration of PEC-MDCK cells was
rather erratic compared with directional movement of PWT-
MDCK cells (Fig. 6; Movies 3 and 5 in supplementary
material). On the other hand, mutant PCT (as well as
PCTQN.N and PCTQN) concentrated at ruffles and microvilli,
although ruffling activity was less intense in these epithelial cell
transfectants (Movie 4 in supplementary material) compared
with fibroblast-like cells expressing PWT, PEC or PCT.N.
Podoplanin-induced EMT involves increased RhoA
activity
Rho GTPases have been found to mediate cytoskeletal
rearrangements and have been implicated in cell migration and
invasiveness (Ridley, 2001; Sahai and Marshall, 2002a). To
ascertain whether podoplanin-induced EMT involved regulation
of Rho GTPases activity, we used biochemical pull-down assays
to analyze the activation state of RhoA, Rac1 and Cdc42 in the
cell transfectants. While in parental MDCK cells or control
clones the overall level of active RhoA (RhoA-GTP) was almost
undetectable (Zondag et al., 2000), the activity of RhoA was
dramatically increased in fibroblastic clones expressing PWT
and PEC (Fig. 7A). Enhanced activation of RhoA was also
found in fibroblastoid PCT.N-MDCK cells, although in this case
the level of active RhoA varied between the two different clones
(clone 1 showed higher RhoA-GTP levels than clone 2). Lysates
from epithelial cells transfected with PCT, PCTQN.N and
PCTQN did not show significant changes in RhoA activation
over basal levels (Fig. 7A and Table 1). In all cases, there was
little change in the total level of expression of RhoA in each of
the transfectants after correcting for protein levels with -tubulin
(data not shown), indicating that activation of RhoA was not due
to an increase in its expression levels. In contrast to RhoA, the
levels of active Rac1 and Cdc42 did not vary substantially in any
of the transfectants with respect to control cells. PWT alone
(without EGFP) was also able to activate RhoA specifically
without changing the levels of active Rac1 and Cdc42 (data not
shown), indicating that this effect is not due to EGFP
modification. On the other hand, we confirmed that the ability
of podoplanin to activate RhoA specifically is not dependent on
a particular cell line, because immortalized HaCaT keratinocytes
Journal of Cell Science 119 (21)
Fig. 7. Podoplanin-induced EMT is associated
with upregulation of RhoA activity. (A) Rho,
Rac and Cdc42 bound to GTP affinity pull-
down assays were used to determine the levels
of active Rho GTPases. Levels of active RhoA,
Rac1 and Cdc42 in MDCK and HaCaT cell
clones transfected with the empty vector
(EGFP) and with wild-type and mutant
podoplanin constructs fused to EGFP.
Quantification of RhoA-GTP expression level
relative to total RhoA level was performed by
densitometric analysis. Values below blots are
relative to control (EGFP) cells, to which an
arbitrary value of 1 was given. Results are
representative of two experiments. (B) Western
blot analysis of ERM phosphorylation relative
to the total expression levels of ezrin and
moesin. The levels of -tubulin were
determined as a control for protein loading.
(C) Western blot analysis of phospho-ERM
levels relative to the total expression levels of
ezrin and moesin in MDCK cells transfected
with the empty vector (EGFP) and PWT before
and after treatment with the Rock inhibitor
Y27632. (D) Inhibition of RhoA signaling
blocks podoplanin-stimulated cell migration. In
vitro wound-healing assays of control (EGFP)
and PWT-MDCK cells were performed (as in
Fig. 5A) in the absence or presence of either
Y27632 (which inhibits Rock) or soluble C3
transferase (which inhibits RhoA, RhoB and
RhoC). Y27632 and C3 transferase reduced
PWT-MDCK cell migration to basal and below
basal levels, respectively. *P<0.05; ***P<0.001
vs PWT-MDCK cells.Jo
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expressing PWT also showed increased RhoA-GTP levels
whereas the levels of Rac1 and Cdc42 bound to GTP remained
unchanged (Fig. 7A). Double immunofluorescence confocal
microscopy analysis revealed that both RhoA and Rac1, but not
Cdc42, colocalized with podoplanin at cell-surface protrusions
in fibroblast-like MDCK cells expressing PWT, PEC, and
PCT.N (Fig. S3 in supplementary material and data not shown).
These results might indicate local activation of both RhoA and
Rac1 at podoplanin-induced filopodia and ruffles even though
no change in the activity of Rac1 was observed in whole-cell
lysates.
Since RhoA-associated kinase (Rock), a downstream effector
of RhoA, has been shown to phosphorylate and activate ERM
proteins (Matsui et al., 1998), we analyzed the status of ERM
phosphorylation in the cell transfectants (Fig. 7B). Increased
levels of phospho-ERM proteins were found in fibroblastic and
fibroblastoid clones with respect to control cells and epithelial
cell transfectants. MDCK cells transfected with PWT alone
(without EGFP) and HaCaT keratinocytes expressing PWT also
showed enhanced phospho-ERM levels (Fig. 7B). Treatment of
PWT-MDCK cells with the Rock inhibitor Y27632 reduced
ERM phosphorylation to basal levels, whereas the inhibitor did
not affect ERM phosphorylation in control cells (Fig. 7C).
These results confirm that podoplanin stimulation of ERM
phosphorylation is mediated by RhoA-dependent activation of
Rock. Moreover, inhibition of either Rock with Y27632 or
RhoA with the exoenzyme C3 transferase blocked podoplanin-
stimulated cell migration (Fig. 7D).
Taken together, these results suggest that to activate RhoA,
podoplanin needs to recruit ERM proteins through its ERM-
binding site. Upregulation of RhoA activity leads to Rock-
mediated ERM phosphorylation and stabilization of ERM
proteins in an open, active conformation (Matsui et al., 1998),
which further strengthens the anchorage of podoplanin to the
cytoskeleton, allowing EMT and enhanced cell migration and
invasion. Therefore, we reasoned that podoplanin-induced
EMT should be prevented by inhibiting the function of either
ezrin or RhoA.
Blocking ezrin or RhoA prevents podoplanin-induced
EMT
In order to analyze the effects of the functional loss of ezrin or
RhoA in podoplanin-mediated EMT, MDCK cells were
cotransfected with PWT and a construct encoding a dominant-
negative form of either ezrin or RhoA. The N-terminal domain
of ezrin (N-ezrin) tagged with vesicular stomatitis virus
glycoprotein G (VSVG) (Crepaldi et al., 1997) and a
hemagglutinin (HA)-tagged N19RhoA mutant form were used
to suppress ezrin and RhoA functions, respectively. The results
of these experiments are shown in Fig. 8. When coexpressed
together with one of these dominant-negative forms,
podoplanin was unable to upregulate RhoA activity (Fig. 8C)
and to promote EMT (Fig. 8A,B). Loss of function of ezrin or
RhoA also suppressed podoplanin stimulation of phospho-
ERM levels (Fig. 8C). These results demonstrated that ezrin
and RhoA play crucial roles in podoplanin-mediated EMT.
Discussion
We show in this work that expression of human podoplanin in
epithelial MDCK cells promotes a complete EMT linked to
downregulation of epithelial genes (E-cadherin, p120 ctn
isoform 3 and cytokeratin 8) and upregulation of mesenchymal
markers (N-cadherin, p120 ctn isoform 1 and fibronectin). This
conversion allowed MDCK cells to acquire migratory features,
including a switch from a relatively slow collective pattern of
cell migration to a faster, individualized cell locomotion
pattern during wound healing, and increased invasiveness
through Matrigel. In several human cancer types,
downregulation of E-cadherin expression is accompanied by
upregulation of mesenchymal N-cadherin, and this cadherin
switch also occurs during EMTs in embryonic development.
N-cadherin appears to exert the opposite effect to that of E-
cadherin, because it promotes cell migration or invasion
instead of cell-cell cohesion (reviewed by Cavallaro and
Christofori, 2004). Interestingly, in podoplanin-induced EMT
the E- to N-cadherin switch correlates with a change in the
expression of p120 ctn isoforms from isoform 3 to isoform 1.
Although this p120 ctn switch was previously observed in
EMTs induced in MDCK cells by the E-cadherin
transcriptional repressors Snail and Slug (Sarrio et al., 2004),
no correlation was found between the levels of these
transcription factors and the expression of p120 ctn isoform 1
in podoplanin-induced EMT, indicating that changes from
p120 ctn isoform 3 to isoform 1 and from E- to N-cadherin do
not necessarily involve upregulation of Snail or Slug.
As also shown in this study, podoplanin induces
upregulation of RhoA activity in MDCK and HaCaT cells.
Since podoplanin promoted cell scattering, but not a complete
EMT in HaCaT keratinocytes (Martín-Villar et al., 2005), these
results indicate that podoplanin-induced RhoA activation in
epithelial cells precedes EMT rather than being a consequence
of it. Several reports have implicated RhoA in epithelial tumor
progression in vivo and in vitro (reviewed by Sahai and
Marshall, 2002a; Lozano et al., 2003). Thus, elevation of RhoA
activity has been found to result in disruption of adherens
junctions and EMT in colon carcinoma cells (Sahai and
Marshall, 2002b), TGF-1-stimulated mammary epithelial
cells (Bhowmick et al., 2001) and Rac1-activated epithelial-
like NIH3T3 cells (Sander et al., 1999). Epithelial MDCK cells
are characterized by high Rac1 and low RhoA activity, and
downregulation of Rac1 activity by oncogenic Ras also leads
to increased RhoA activity and EMT (Zondag et al., 2000). The
fact that podoplanin is able to activate RhoA without affecting
Rac1 or Cdc42 activity suggests a direct link between
podoplanin expression and RhoA activation in MDCK cells,
but does not exclude a role for Rac1 or Cdc42 in podoplanin-
mediated cell motility. In fact, Rac1 colocalizes with
podoplanin at cell-surface protrusions in podoplanin-induced
MDCK fibroblastic cells. Whereas Rac1 and Cdc42 have been
involved in the establishment and maintenance of epithelial
intercellular adhesions and are respectively required for
lamellipodium and filopodium extensions in migrating cells,
RhoA is implicated in the generation of contractile force, and
in moving the body and tail of the cell behind the leading edge
(Ridley, 2001). As podoplanin clusters on the cell tail just
before tail retraction is completed, it would have a direct role
in retractive processes by activating RhoA on the trailing edge.
The crucial podoplanin structural motif involved in RhoA
activation and EMT seems to reside in the endodomain,
because its deletion (PCT) prevented upregulation of RhoA
activity and halted conversion to a fibroblast-like phenotype,
whereas deletion of the ectodomain (PEC) did not. The
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cytoplasmic tail of podoplanin (RKMSGRYSP) is extremely
short and binds directly to ezrin and moesin through a cluster
of three basic residues (bold). In vivo, the interaction of
podoplanin with ezrin appears to be mainly mediated by the
juxtamembrane dipeptide RK, because substitution of these
two or all three basic residues by uncharged polar amino acids
(PCTQN or PCTQN.N) had the same effect as deletion of the
entire cytoplasmic tail (PCT) in blocking podoplanin
association with ezrin. By contrast, mutation of the most C-
terminal residue R159 (PCT.N) impaired, but did not prevent,
podoplanin-ezrin interaction. PCT, PCTQN and PCTQN.N
were unable to induce RhoA activation and EMT, whereas
PCT.N pushed MDCK cells to an intermediate phenotype (the
so-called fibroblastoid phenotype) characterized by mixed
expression of epithelial (i.e. E-cadherin) and mesenchymal
(i.e. N-cadherin) protein markers and by a fibroblast-like
morphology and migratory behavior. Overall, these results
suggested that podoplanin needs to recruit ERM proteins
through the endodomain in order to activate RhoA and promote
EMT, and this hypothesis was confirmed by loss-of-function
experiments. Suppression of the function of either ezrin or
RhoA by the introduction in MDCK cells of a dominant-
negative form of any of these proteins blocked podoplanin-
induced RhoA activation and EMT. An intriguing question is
how podoplanin expression in MDCK cells leads to RhoA
activation. We speculate that this could occur by a similar
mechanism to that exhibited by the hyaluronan receptor CD44.
Hirao and coworkers found that Rho-GDP dissociation
inhibitor (Rho-GDI), which sequesters Rho GTPases bound
to GDP in the cytoplasm, could be coimmunoprecipitated
together with CD44-ERM complexes (Hirao et al., 1996). The
binding of Rho-GDI to the exposed N-ERMAD domain of
ERM proteins releases RhoA-GDP from the inhibitor, allowing
its activation by a GDP-GTP exchange factor (Takahashi et al.,
Journal of Cell Science 119 (21)
Fig. 8. Dominant-negative effects of N19RhoA and of N-terminal domain of ezrin (N-ezrin) in podoplanin-induced EMT. (A) Phase-contrast
micrographs and confocal fluorescence detection of podoplanin in MDCK cells cotransfected with EGFP-tagged PWT and N-ezrin or
N19RhoA. Control cells expressing EGFP alone, EGFP/N-ezrin and EGFP/N19RhoA are also shown. Confocal images are maximum
projections of horizontal optical sections through the whole depth of the transfectants. (B) Western blot analysis of N-ezrin (VSVG), N19RhoA
(HA) and differentiation-related proteins in MDCK cell transfectants. N-ezrin and N19RhoA expression was determined by using antibodies
against their respective tags. (C) N-ezrin and N19RhoA inhibits podoplanin-mediated RhoA activation and ERM phosphorylation. The levels of
RhoA-GTP relative to the levels of total RhoA and the levels of phospho-ERM relative to the total expression levels of ezrin and moesin are
shown. The expression of -tubulin was determined as a control for protein loading.
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1997; Takahashi et al., 1998). Thus, podoplanin recruitment of
ezrin and/or moesin to the membrane not only would mediate
its anchorage to the actin cytoskeleton but also would activate
RhoA facilitating EMT. In this regard, it has been shown that
ezrin influences the metastatic potential of tumor cell lines, at
least in part, through activation of RhoA (Yu et al., 2004). Once
activated, RhoA can contribute to stabilize ERM proteins
further in an active conformation either by Rock-dependent
phosphorylation of a T residue in the C-terminal domain, as
shown in this work, or by RhoA-dependent production of PIP2
(Tsukita and Yonemura, 1999; Ivetic and Ridley, 2004).
A recent report (Wicki et al., 2006) has described podoplanin
stimulation of collective cell migration and invasion (in the
absence of EMT) in MCF7 breast carcinoma cells. This effect
was mediated by the induction of filopodia-like structures in
the migrating front, and, surprisingly, involved combined
inactivation of RhoA, Rac1 and Cdc42, although only
inhibition of RhoA signaling appeared to mediate filopodia
formation. These results suggest a direct role of podoplanin in
stimulating epithelial cell migration independently of
promoting EMT, and are in line with our previous observations
suggesting that the extent of podoplanin-mediated phenotypic
changes is dependent on the cell type or the state of cellular
differentiation. Thus, podoplanin induces filopodia formation
in human immortalized HaCaT keratinocytes, but fails to
downregulate E-cadherin expression and to promote a
complete EMT (Martín-Villar et al., 2005). This is in contrast
to the profound phenotypic changes induced by podoplanin in
MDCK, a highly sensitive cell line, which undergoes EMT in
the presence of different inducers (Gotzman et al., 2004). A
major discrepancy with the results of Wicki and co-workers is
the fact that, in our hands, podoplanin activates RhoA without
affecting Rac1 and Cdc42 activities in both MDCK and HaCaT
cells. In MCF7 cells, stimulation of cell migration is associated
with RhoA inhibition, whereas the opposite is true in MCDK
cells. It is well established that RhoA activation can either
inhibit or promote cell migration in distinct cell types (see
Ridley, 2004; Lozano et al., 2005). This fact probably reflects
a particular organization of the cellular cytoskeleton
(microfilaments, microtubules and intermediate filaments) and
of adhesion components, as well as a different way for Rho
GTPases to coordinately regulate cell migration. As a matter
of fact, while the basal level of active RhoA is relatively high
in MCF7 cells (Wicki et al., 2006), it is low in MDCK and
HaCaT cells compared with the levels of active Rac and Cdc42
(Zondag et al., 2000) (this paper). After all, both situations, i.e.
podoplanin stimulation of in vitro cell migration or invasion
with and without EMT, are compatible with the in vivo data.
In many human carcinomas, podoplanin is coexpressed
together with E-cadherin in the invasive front of the tumors
(Wicki et al., 2006), but we also found that the presence of
podoplanin coincides with the loss of E-cadherin expression in
the invasive front of some oral squamous cell carcinomas
(Martin-Villar et al., 2005). 
Interestingly, epithelial MDCK cells expressing mutant
PCT consistently showed loose cell-cell contacts and
enhanced migratory and invasive abilities in comparison with
control cells or cells expressing PCTQN.N and PCTQN. These
results suggest that the podoplanin CT domain might contain
residues that positively affect the stability of adherens
junctions. These residues should be other than those involved
in ERM binding or should become functional when the ERM-
binding sites are inactivated. This hypothesis is supported by
the fact that PCTQN.N, PCTQN and PCT mutant proteins
are expressed at cell-cell contacts in epithelial MDCK cells. In
this regard, Wicki and co-workers observed that the majority
of pancreatic carcinomas in a transgenic mouse model
(Rip1Podo;Rip1Tag2) with targeted expression of podoplanin
in  cells of islets of Langerhans retained E-cadherin
expression whereas it was lost in most carcinomas of control
mice (Wicki et al., 2006). Yet, at present, we do not have a
rational explanation for the unexpected phenotype of PCT-
MDCK cell transfectants. Other observations related to the
phenotypes of MDCK cells expressing PCT.N and PEC
suggest that podoplanin can influence cell spreading. Both
types of fibroblast-like cell transfectants showed smaller focal
contacts and fewer stress fibers when compared with well-
spread MDCK cells expressing PWT. Since podoplanin
appears to be absent from focal contacts and does not associate
with stress fibers (Scholl et al., 1999), these observations
suggest that the ectodomain, and possibly its interaction with
extracellular components could affect the dynamics of cell to
substratum adhesion. It has been found that podoplanin induces
platelet aggregation through the EC domain (Kato et al.,
2003; Kaneko et al., 2006). In addition, we have obtained
experimental evidence indicating that podoplanin interacts
with extracellular matrix components (unpublished results).
These data suggest an adhesive role for this glycoprotein. The
interaction of podoplanin with extracellular components might
be mechanically transmitted to the actin cytoskeleton through
the cytoplasmic tail, as occurs with most, if not all, membrane
adhesion receptors (Brunton et al., 2004). Thus, the inability
of podoplanin to bind to extracellular components (PEC) or
the diminished or inappropriate interaction of podoplanin with
intracellular molecules involved in actin dynamics (PCT.N)
could affect the dynamics of focal adhesions.
A final point brought to the discussion is the fact that
although podoplanin-induced EMT is dependent on the
interaction of the cytoplasmic tail with ERM proteins and then
with the cytoskeleton, the localization of podoplanin at cell-
surface protrusions requires neither the endodomain nor the
ectodomain, pointing to the transmembrane domain as the
structural element responsible for the presence of podoplanin
within this particular membrane region. This might be
mediated by the association of the podoplanin TM domain with
lipid rafts, as occurs with CD44 (Perschl et al., 1995). It has
been proposed that protrusive motility at the cell surface might
be regulated through the local accumulation of raft domains
enriched in PIP2 (Yin and Janmey, 2003; Golub and Caroni,
2005). The implication of the podoplanin TM domain in the
localization of this glycoprotein at cell-surface protrusions and
its possible interaction with lipid rafts is currently being
investigated.
Materials and Methods
Constructs
Constructs for GST fusion proteins of the podoplanin CT were generated by
synthesizing each cDNA carrying EcoRI and XhoI restriction sites to facilitate
subcloning into the pGEX-4T1 vector (Amersham Biosciences). cDNAs for the CT
of CD44 and full-length ezrin or its N-ERMAD region (residues 1-310) were
obtained by PCR amplification from HT1080 and HeLa cells, respectively.
Constructs for GST-full-length moesin and its N-ERMAD region were a gift from
Francisco Sánchez-Madrid (Hospital de la Princesa, Madrid, Spain) and constructs
for tagged dominant-negative forms of ezrin (N-ezrin) and RhoA (N19RhoA) were
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kindly provided by Paul Mangeat (University of Montpellier, France) and Piero
Crespo (Instituto de Investigaciones Biomédicas, Madrid, Spain), respectively. Ezrin
tagged with ECFP at the C-terminus, EYFP- and EGFP-tagged podoplanin
constructs were obtained by PCR amplification using primers that carry both the
desired mutation (in the case of podoplanin mutant constructs) and a convenient
restriction site to facilitate subcloning into pECFP-N1, pEYFP-N1, pEGFP-N1 and
pEGFP-C1 vectors. Oligonucleotides used for amplification of all these constructs
are described in Table S1 in supplementary material. All PCR-derived constructs
were sequenced in an ABI Prism 377 system (Perkin Elmer) to confirm that
nucleotide sequences were correct.
RT-PCR analysis
RT-PCR analysis was carried out as described previously (Martín-Villar et al.,
2005). Canine PCR products were obtained after 30-35 cycles of amplification with
an annealing temperature of 60-65°C. Primer sequences for canine E-cadherin
(CDH1), Snail and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) have
been described elsewhere (Peinado et al., 2003). For canine Slug the following
oligonucleotides were used: 5-AGTGATTATTTCCCCATATCTCTATGA-3 and
5-GTAGTCTTTCCTCTTCATCACTAATGG-3 (amplifies a fragment of 300 bp).
Cell culture conditions and cDNA transfections
Cell culture conditions and transfection procedures were as previously described
(Martín-Villar et al., 2005). MDCK cell transfectants were selected in 0.5 mg/ml of
G418 (Promega) for 2 weeks. Individual clones were isolated with cloning rings.
For FRET experiments, MDCK cells at 60-70% confluence were cotransfected with
Ezrin-ECFP and EYFP-tagged podoplanin constructs. Cells selected in 0.5 mg/ml
of G418 for 10 days were plated onto coverslips, fixed with 3.7% formaldehyde and
mounted on Mowiol. The Rock inhibitor Y27632 (Calbiochem) and the cell
permeable recombinant C3 transferase (Cytoskeleton) were added to the cell
cultures at 5 M and 2 g/ml, respectively. For treatments with C3 transferase, a
0.1% concentration of serum was used in the cultures.
In vitro binding assay between ERM and GST fusion proteins
GST and GST fusion proteins were produced in E. coli BL21 cells as described
(Sander et al., 1998). Pure dialyzed GST and GST fusion proteins were bound to
CNBr-activated Sepharose (Amersham Pharmacia Biotech) according to the
manufacturer’s instructions. Approximately 1 nmol of pure dialyzed full-length
ezrin or moesin and their respective N-ERMADs were mixed with 500 pmol of
fusion proteins bound to Sepharose in a final volume of 500 l of binding buffer
(50 mM Tris-HCl pH 7.5, 1 mM MgCl2, 100 mM NaCl, 0.4% Triton X-100), in the
presence or absence of 50 g/ml PIP2 (Sigma-Aldrich), and incubated for 30
minutes at room temperature. Beads were then washed six times in binding buffer,
boiled in Laemmli buffer, and bound ERMs analyzed by western blotting.
Western blot analysis and antibodies
Cell lysates were obtained in RIPA buffer (0.1% SDS, 0.5% sodium deoxycholate,
1% NP-40, 150 mM NaCl, 50 mM Tris-HCl pH 7.5 and a cocktail of protease
inhibitors) and analyzed by western blotting. Polyclonal antibodies against ezrin and
moesin were kindly provided by Paul Mangeat; anti-phospho-ERM antibody was
from Cell Signaling Technology; antibodies for RhoA and HA were from Santa
Cruz Biotechnology; antibodies for EGFP, fibronectin, VSVG and -tubulin (mAb
DM1A) were from Sigma-Aldrich; mAbs for p120ctn, -catenin (C19220), Rac1
and Cdc42 were from BD Biosciences; and mAbs for N-cadherin, vimentin and
cytokeratin 8 from Zymed Laboratories, Dako and Progen, respectively.
Horseradish-peroxidase-conjugated sheep anti-mouse (Amersham Biosciences),
goat anti-rat (Pierce) and goat anti-rabbit (Nordic) IgGs were used as secondary
antibodies.
Immunofluorescence analysis and time-lapse confocal
microscopy
Detection of E-cadherin and -catenin was performed on confluent cells grown on
glass coverslips and fixed in cold methanol using mAbs 4A2C7 (Zymed) and
C19220 (BD Biosciences), respectively. Detection of vimentin, fibronectin, ezrin,
vinculin, RhoA, Rac1 and F-actin was performed in cells fixed with 3.7%
formaldehyde in PBS and permeabilized with 0.05% Triton X-100. The mAb 3C12
(Sigma-Aldrich) was used for detection of ezrin. For F-actin staining, phalloidin
coupled to Alexa Fluor 594 (Molecular Probes) was used. Secondary antibodies
were Alexa Fluor 594-labeled anti-rabbit or anti-mouse IgGs (Molecular Probes).
Staining of nuclei was performed in a 1 g/ml solution of 4,6-diamino-2-
phenilindole (DAPI; Sigma-Aldrich). Confocal laser-scanning microscopy was
performed in a Leica TCS-SP2 microscope (Leica Microsystems, Heidelberg,
Germany). Images were taken using a 63 (NA 1.32) oil-immersion objective and
assembled using Leica Confocal Software 2.0.
For in vivo podoplanin pre-embedding staining, subconfluent cells grown on glass
coverslips were incubated in DMEM containing 25 mM HEPES and 1% BSA
(buffer D) for 15 minutes, and stained with rabbit anti-podoplanin (Martín-Villar et
al., 2005) or rabbit anti-EGFP A11122 (Molecular Probes) antibodies at 1:100
dilution in buffer D for 1 hour at 4°C. Alexa Fluor 594-labeled anti-rabbit IgG
(Molecular Probes) was used as secondary antibody. Coverslips were then fixed with
3.7% paraformaldehyde in buffer D, mounted on Mowiol and examined in a Leica
TCS-SP2 confocal scanning laser microscope.
For time-lapse confocal microscopy, cells grown at low confluence on glass-
bottom dishes (Lab-Tek® II) were maintained at 37°C in a 5% CO2 atmosphere
using an incubation system. Confocal series of fluorescence images (22 slices of
0.5 m) were simultaneously obtained with a 63/1.32 oil immersion objective
every 10 minutes intervals for 4 hours. Images were processed and assembled into
movies using the Leica Confocal Software 2.0 and Adobe Premiere Pro 1.5
software.
FRET by acceptor photobleaching
FRET was examined by the acceptor photobleaching method with EYFP-tagged
podoplanin and ECFP-tagged ezrin incorporated into MDCK cells. A Leica TCS-
SP2 confocal scanning laser microscope equipped with a 63/1.32 oil-immersion
lens was used. Energy transfer was detected as an increase in donor fluorescence
(CFP) after photobleaching of the acceptor molecules (EYFP). ECFP and EYFP
emission signals were collected before and after EYFP photobleaching by using the
458 nm or 514 nm laser lines, respectively. Images were background corrected and
the FRETeff was calculated for each pixel from the increase of the donor
fluorescence: FRETeff=(Dpost–Dpre)/Dpost; for all Dpost>Dpre, where Dpre and Dpost are
the donor fluorescence intensities before and after acceptor photobleaching,
respectively.
Wound healing assay and time-lapse video microscopy
The migratory behavior of cell transfectants was analyzed in an in vitro wound-
healing assay, as described previously (Scholl et al., 1999). Wounded cell cultures
were maintained at 37°C in a 5% CO2 atmosphere using an incubation system.
Images of the wounds were acquired every 10 minutes for 12 hours using a Zeiss
Axiovert 135 TV inverted microscope equipped with a Digital JVC video camera.
Quantification of migrated cells was done by measuring the number of pixels in the
wounded area at different times using Adobe® Photoshop®. Images and videos were
assembled using Analysis® 3.2 (Soft Imaging System) and Adobe Premiere Pro 1.5
software.
In vitro invasion assay
Cells (2.5104) were suspended in 500 l DMEM and loaded onto the upper
compartment of BD BioCoatTM MatrigelTM Invasion Chamber (BD Biosciences).
5% FBS was used as a chemoattractant in the lower compartment. Cell invasion
was analyzed by detection of EGFP using a Leica TCS-SP2 confocal microscope
equipped with a 20/0.70 and 63/1.32 oil immersion lens. Fluorescence intensity
profiles were obtained by image analysis using Leica Confocal Software 2.0.
RhoA, Rac1 and Cdc42 activity assays
The level of active RhoA (RhoA-GTP) in cell lysates was measured using a GST
fusion protein with the RhoA-binding domain of Rhotekin (GST-C21). For Rac1
and Cdc42 activities, a GST fusion protein of the binding domain of PAK (GST-
PAK) was used. Assays were performed as described by Sander and co-workers
(Sander et al., 1998).
Statistics
Data are presented as mean ± s.e.m. Significance was determined using the Student’s
t-test. All statistical analyses were performed using GraphPad Prism 4.0 software.
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